1. bookVolume 70 (2021): Issue 1 (June 2021)
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
access type Open Access

COVID-19 disease in the pulmonology unit of a dedicated COVID-19 hospital – our experience

Published Online: 28 May 2022
Volume & Issue: Volume 70 (2021) - Issue 1 (June 2021)
Page range: 18 - 25
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
Abstract

Background: The Coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has led to a global health care crisis. We report profiles of cases admitted to our hospital.

Methods: We conducted this study at the pulmonology unit of a Dedicated COVID Hospital (DCH) of Western India. This is a prospective observational study which analysed the demographical data, clinical parameters, comorbidities, complications and laboratory and outcome parameters.

Results: Our study included 101 patients. The mean age was 43 years; 64 (63.3%) were men and 37 (36.7%) women. Out of 101, 6 (6%) had mild, 30 (30%) had moderate and 65 (64%) had severe COVID-19 disease. Severity increased with age and comorbidities. Ninety-four (94%) had pneumonia. Of these 94, 65 (69%) patients had acute respiratory distress syndrome (ARDS). Twenty-one (21%) were mild, 20 (31%) moderate and 24 (37%) severe ARDS. ARDS severity increased with age and in men. Thirty-six (36%) required oxygenation only and 29 (29%) required additional ventilatory management – mostly non-invasive ventilation (NIV). The laboratory values analysis revealed elevation of D-dimers level in 66 (65.3%) and IL6 in 68 (67.3%). Diabetes mellitus (DM) and hypertension (HT) were the common comorbidities. Totally three (2.97%) patients died due to COVID-19 infection. Mortality was associated with HT and myocarditis. Mean duration of hospital stay was 15 days, and it increased with increasing severity of disease and ARDS.

Conclusion: COVID-19 is common in the adult with male preponderance. The majority recovered with a good outcome. Comorbidities affected outcome adversely.

Keywords

1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019—COVID-19. Clinical Microbiology Reviews. 2020;33: e00028–e00020.10.1128/CMR.00028-20Search in Google Scholar

2. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, Mcginn T, Davidson KW. Presenting characteristics, comorbidities and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323: 2052–2059.10.1001/jama.2020.6775Search in Google Scholar

3. Huang C, Wang Y, Li X, Ren Li, Zhao J, Hu Yi, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223): 497–506.10.1016/S0140-6736(20)30183-5Search in Google Scholar

4. Ministry of Health & Family Welfare, Government of India. Revised guidelines on clinical management of COVID-19. Available from: https://www.mohfw.gov.in/pdf/RevisedNational-ClinicalManagementGuidelineforCOVID1931032020.pdf [Accessed 20th June 2020].Search in Google Scholar

5. World Health Organization. Clinical management of COVID-19. Available from: https://www.who.int/publicationsdetail-redirect/clinical-anagement-of-covid-19 [Accessed 22nd November 2020].Search in Google Scholar

6. Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Clinical management of COVID-19. Indian Journal of Medical Research. 2020;151(5): 401–410.10.4103/ijmr.IJMR_957_20753043532611911Search in Google Scholar

7. Indian Council of Medical Research. Available from: https://main.icmr.nic.in/content/covid-19 [Accessed 22nd November 2020].Search in Google Scholar

8. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England Journal of Medicine. 2000;342: 1301–1308.10.1056/NEJM20000504342180110793162Search in Google Scholar

9. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Archives for Chest Disease. 2020;90: 1294.10.4081/monaldi.2020.129432290644Search in Google Scholar

10. Pande D, Kochhar A, Saini S, Ganapathy U, Gogia AR. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian Journal of Palliative Care. 2020;26(Suppl S1): 36–39.10.4103/IJPC.IJPC_146_20753498233088084Search in Google Scholar

11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11): 1061–1069.10.1001/jama.2020.1585704288132031570Search in Google Scholar

12. Budhiraja S, Soni A, Jha V, Indrayan A, Dewan A, Singh O, et al. Clinical profile of first 1000 COVID-19 cases admitted at tertiary care hospitals and the correlates of their mortality: an Indian experience. medRxiv. 2020.11.16.20232223. Available from: doi:10.1101/2020.11.16.20232223.10.1101/2020.11.16.20232223Search in Google Scholar

13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18): 1708–1720.10.1056/NEJMoa2002032709281932109013Search in Google Scholar

14. Kaur N, Gupta I, Singh H, Karia R, Ashraf A, Habib A, et al. Epidemiological and clinical characteristics of 6635 COVID-19 patients: a pooled analysis. SN Comprehensive Clinical Medicine. 2020;9: 1–5. Available from: doi:10.1007/s42399-020-00393-y.10.1007/s42399-020-00393-y734340732838160Search in Google Scholar

15. Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care centre in New Delhi. Journal of the Association of Physicians of India. 2020;68(7): 19–26.Search in Google Scholar

16. Tian S, Liu H, Liao M, Wu Y, Yang C, Cai Y, et al. Analysis of mortality in patients With COVID-19: clinical and laboratory parameters. Open Forum Infectious Diseases. 2020;7(5): ofaa152.10.1093/ofid/ofaa152719755632457924Search in Google Scholar

17. Saluja M, Pillai D, Jeliya S, Bauddh N, Chandel R. COVID 19-clinical profile, radiological presentation, prognostic predictors, complications and outcome: A perspective from the Indian sub-continent. Journal of the Association of Physicians of India. 2020;68(7): 13–18.Search in Google Scholar

18. Bhatraju PK, Ghassemeih BJ, Nichols M, Kim R, Jierome KR, Nalla AK, et al. Covid-19 in critically Ill patients in the Seattle Region – Case series. The New England Journal of Medicine. 2020;382: 2012–2022.10.1056/NEJMoa2004500714316432227758Search in Google Scholar

19. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-cov-2 in Wuhan, China. Allergy. 2020;75(7): 1730–1741.10.1111/all.1423832077115Search in Google Scholar

20. Bhandari S, Bhargava A, Sharma S, Keshwani P, Sharma R, Banerjee S. Clinical profile of Covid-19 infected patients admitted in a tertiary care hospital in North India. Journal of the Association of Physicians of India. 2020;68(5): 13–17.Search in Google Scholar

21. Shrestha DB, Budhathoki P, Syed N, Rawal E, Raut S, Khadka S. Remdesivir: A potential game changer or just a myth? A systematic review and meta-analysis. Life Sciences. 2020;26: 118663. doi: 10.1016/j.lfs.2020.118663.10.1016/j.lfs.2020.118663758610533121991Search in Google Scholar

22. Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P. Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis. Virology Journal. 2020;17: 141.10.1186/s12985-020-01412-z751221832972430Search in Google Scholar

23. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective. Diabetology & Metabolic Syndrome. 2020;14(5): 971–978.10.1016/j.dsx.2020.06.054732071332610262Search in Google Scholar

24. Focosi D, Anderson AO, Tang JW, Tuccori M. Convalescent plasma therapy for COVID-19: state of the art. Clinical Microbiology Reviews. 2020;33(4): e00072-20.10.1128/CMR.00072-20743029332792417Search in Google Scholar

25. Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo Am, Garcia Ch, et al. Repurposed antiviral drugs for COVID-19 – interim WHO SOLIDARITY trial results. WHO Solidarity Trial Consortium. The New England Journal of Medicine. 2021;384:497–511.Search in Google Scholar

26. Fu L, Li XY, Fei J, Xiang Y, Xiang HX, Li MD, et al. Myocardial injury at early stage and its association with the risk of death in COVID-19 patients: A Hospital-Based Retrospective Cohort Study. Frontiers in Cardiovascular Medicine. 2020;7: 590688.10.3389/fcvm.2020.590688766163633195480Search in Google Scholar

27. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American College of Cardiology. 2020;75(23): 2950–2973. Available from: doi:10.1016/j.jacc.2020.04.031.10.1016/j.jacc.2020.04.031716488132311448Search in Google Scholar

28. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369: m1985.10.1136/bmj.m1985724303632444460Search in Google Scholar

29. Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian Journal of Medical Research. 2020;152(1 & 2): 61–69.10.4103/ijmr.IJMR_1788_20785326032773414Search in Google Scholar

30. Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al. Clinical characteristics and outcomes of critically ill patients with novel corona-virus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Medicine. 2020;46(10): 1863–1872.10.1007/s00134-020-06211-2743924032816098Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo